⌘K
Loading ticker…
Lexaria Bioscience Corp. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Lexaria Bioscience Corp. Common Stock (LEXX) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 0.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
11 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LEXX is in a stage 4 downtrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -21.9% / -36.5%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LEXX appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $173K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $173K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LEXX Jan avg: 15.25% median: 23.11% win: 75% σ: 21.18% n: 4 2022-04-12 → 2026-05-29 | LEXX Feb avg: 24.54% median: -8.21% win: 25% σ: 71.48% n: 4 2022-04-12 → 2026-05-29 | LEXX Mar avg: 5.73% median: 8.40% win: 75% σ: 11.57% n: 4 2022-04-12 → 2026-05-29 | LEXX Apr avg: -19.88% median: -15.51% win: 0% σ: 7.82% n: 5 2022-04-12 → 2026-05-29 | LEXX May avg: -17.11% median: -12.07% win: 20% σ: 32.68% n: 5 2022-04-12 → 2026-05-29 | LEXX Jun avg: 0.11% median: -8.19% win: 25% σ: 32.10% n: 4 2022-04-12 → 2026-05-29 (current) | LEXX Jul avg: 13.83% median: 8.79% win: 75% σ: 24.19% n: 4 2022-04-12 → 2026-05-29 | LEXX Aug avg: 7.25% median: 3.72% win: 50% σ: 13.91% n: 4 2022-04-12 → 2026-05-29 | LEXX Sep avg: -8.94% median: -11.00% win: 25% σ: 13.55% n: 4 2022-04-12 → 2026-05-29 | LEXX Oct avg: 1.44% median: -1.37% win: 50% σ: 28.60% n: 4 2022-04-12 → 2026-05-29 | LEXX Nov avg: 11.56% median: 7.78% win: 75% σ: 15.82% n: 4 2022-04-12 → 2026-05-29 | LEXX Dec avg: -19.00% median: -16.78% win: 25% σ: 18.29% n: 4 2022-04-12 → 2026-05-29 |